Pharmafile Logo
Pharmafocus logo
Advanced Search
fda2outsideweb

AZ and MSD’s Lynparza becomes first PARP inhibitor approved in US for metastatic breast cancer

January 15, 2018
Sales and Marketing AstraZeneca, Cancer, FDA, MSD, breast cancer, lynparza, pharma

The FDA has announced that it has awarded marketing authorisation in the US to Lynparza (olaparib), a poly ADP-ribose polymerase …

News
flu

Universal flu vaccine receives Google’s financial backing

January 15, 2018
Sales and Marketing Vaccine, biotech, drugs, flu, pharma, pharmaceutical

Vaccitech, a spin-out company from the University of Oxford, recently launched a Series A financing round and had some fairly …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

January 12, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, HIV, J&J, JJ, Johnson & Johnson, Pfizer, Shire, Teva, Xarelto, patient reported outcomes

The Xmas break is now a distant memory as we move further into January, and with another Friday comes another …

News
kid_ill

FDA steps in to prohibit codeine cough syrups for children

January 12, 2018
Medical Communications FDA, biotech, drugs, pharma, pharmaceutical

The FDA has announced that it will require all labels to state that cough syrups containing codeine or hydrocodone are …

News
roche_close

Roche’s Ocrevus gets the go ahead in Europe for two forms of MS

January 12, 2018
Medical Communications, Sales and Marketing Europe, European Commission, Ocrevus, Roche, multiple sclerosis, pharma

Roche has revealed that its multiple sclerosis (MS) drug Ocrevus (ocrelizumab) has been awarded marketing approval in Europe by the …

News
breast_cancer_awareness

BRCA gene mutation found not to impact survival

January 12, 2018
Medical Communications, Research and Development

The BRCA1 and BRCA2 genes are known to significantly increase the chances of a woman developing cancer and it was …

News
old_man_bar

Another Alzheimer’s drug bites the dust in P3

January 12, 2018
Medical Communications, Research and Development Alzheimer's, biotech, drugs, pharma, pharmaceutical

It’s been a terrible week for Alzheimer’s disease research, after Pfizer shuttered its neuroscience unit and

News
barrett_novartis

Novartis prises Pfizer’s Oncology Head away

January 11, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Pfizer, biotech, drugs, pharma, pharmaceutical

Novartis has been looking to find someone to fill the shoes of Bruno Strigini since it was revealed that he …

Appointment
teva_small

Teva execs feel the pinch, after pay halved

January 11, 2018
Medical Communications, Sales and Marketing Teva, biotech, drugs, pharma, pharmaceutical

Teva’s current crisis is built upon problems that run deep into the company, after numerous acquisitions left it bloated and …

News

AZ’s Fasenra approved in Europe as an add-on for severe eosinophilic asthma

January 11, 2018
Research and Development AstraZeneca, European Commission, Fasenra, MedImmune, asthma, pharma

AstraZeneca and its biologics R&D unit MedImmune have announced that their drug Fasenra (benralizumab) has received approval from the European …

News
truvada-web

AIDS charity lambasts “ethically challenged” Gilead over price hikes

January 11, 2018
Sales and Marketing AIDS, Gilead, HIV, Truvada, biotech, drugs, pharma, pharmaceutical

The AIDS Healthcare Foundation (AHF) has strongly criticised Gilead prices increases across the board for its HIV and AIDS treatment, …

News
mr058666-web

Nestle reportedly pulls out in front to buy Merck KGaA consumer health unit with $5 billion bid

January 11, 2018
Sales and Marketing Merck KGaA, nestle, pharma

It has been reported that Swiss food giant Nestle has pulled out in front as the top bidder for Merck …

News
nhs_sign

NHS no longer able to deliver on standards, warn bosses

January 11, 2018
Medical Communications NHS, biotech, drugs, pharma, pharmaceutical

The struggles of the NHS this winter are no secret, especially after being front and centre of the first Prime …

News

Dr Aidan Murphy becomes Ipsen’s new Executive VP, Technical Operations

January 10, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ipsen, pharma

Dr Aidan Murphy has been named by Ipsen’s new Executive Vice President, Technical Operations, succeeding Jonathan Barnsley who retired at …

Appointment

Lundbeck partners with Vanderbilt University on schizophrenia research project

January 10, 2018
Research and Development

Danish pharmaceutical firm Lundbeck has signed a separate licensing and research collaboration agreement with Tennessee’s Vanderbilt University to develop a …

News
hands-981400_960_720

New project examining FDA-approved drugs for Alzheimer’s, worries over research remains

January 10, 2018
Research and Development Alzheimer's, biotech, drugs, pharma, pharmaceutical

It’s been a gloomy period for research into Alzheimer’s disease treatments in the last week, Pfizer announced it would be …

News
xarelto_10_tablet1

Bayer and J&J successfully reverse $28 million Xarelto court payout

January 10, 2018
Research and Development, Sales and Marketing Bayer, J&J, JJ, Johnson & Johnson, Xarelto, pharma

Bayer and Johnson & Johnson have managed to avert a payout of $27.8 million after a Pennsylvania state court judge …

News
mit-drug-delivery-01_0

Slow-release, once-weekly pill for HIV developed

January 10, 2018
Research and Development HIV, Lyndra, biotech, drugs, pharma, pharmaceutical

Patient adherence is a big issue across the healthcare system, where individuals, even with the most serious conditions, do not …

News
digestive_tract_pill

Swallowable capsules could revolutionise bowel disorder treatment

January 9, 2018
Research and Development biotech, drugs, pharma, pharmaceutical

Researchers from RMIT University in Australia were tasked with developing a more effective breath test for determining what was happening …

News
2000px-flag_of_sri_lanka

Sri Lanka to build first-ever pharmaceutical manufacturing zone

January 9, 2018
Manufacturing and Production Pharma Zone, Sri Lanka, manufacturing, pharma

Sri Lanka is set to build its first-ever exclusive pharmaceutical manufacturing zone, it has emerged. The State Pharmaceuticals Manufacturing Corporation …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026